BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 15846190)

  • 1. Should we offer expectant management in cases of severe preterm preeclampsia with fetal growth restriction?
    Shear RM; Rinfret D; Leduc L
    Am J Obstet Gynecol; 2005 Apr; 192(4):1119-25. PubMed ID: 15846190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Benefits and risks of expectant management of severe preeclampsia at less than 26 weeks gestation: the impact of gestational age and severe fetal growth restriction.
    Belghiti J; Kayem G; Tsatsaris V; Goffinet F; Sibai BM; Haddad B
    Am J Obstet Gynecol; 2011 Nov; 205(5):465.e1-6. PubMed ID: 21889120
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The impact of fetal growth restriction on latency in the setting of expectant management of preeclampsia.
    McKinney D; Boyd H; Langager A; Oswald M; Pfister A; Warshak CR
    Am J Obstet Gynecol; 2016 Mar; 214(3):395.e1-7. PubMed ID: 26767794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Are perinatal and maternal outcomes different during expectant management of severe preeclampsia in the presence of intrauterine growth restriction?
    Haddad B; Kayem G; Deis S; Sibai BM
    Am J Obstet Gynecol; 2007 Mar; 196(3):237.e1-5. PubMed ID: 17346535
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Maternal and perinatal outcomes during expectant management of 239 severe preeclamptic women between 24 and 33 weeks' gestation.
    Haddad B; Deis S; Goffinet F; Paniel BJ; Cabrol D; Siba BM
    Am J Obstet Gynecol; 2004 Jun; 190(6):1590-5; discussion 1595-7. PubMed ID: 15284743
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expectant management of severe preterm preeclampsia: is intrauterine growth restriction an indication for immediate delivery?
    Chammas MF; Nguyen TM; Li MA; Nuwayhid BS; Castro LC
    Am J Obstet Gynecol; 2000 Oct; 183(4):853-8. PubMed ID: 11035325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The risks of spontaneous preterm delivery and perinatal mortality in relation to size at birth according to fetal versus neonatal growth standards.
    Lackman F; Capewell V; Richardson B; daSilva O; Gagnon R
    Am J Obstet Gynecol; 2001 Apr; 184(5):946-53. PubMed ID: 11303203
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multicenter screening for pre-eclampsia and fetal growth restriction by transvaginal uterine artery Doppler at 23 weeks of gestation.
    Papageorghiou AT; Yu CK; Bindra R; Pandis G; Nicolaides KH;
    Ultrasound Obstet Gynecol; 2001 Nov; 18(5):441-9. PubMed ID: 11844162
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Doppler sonography of uterine arteries at 20-23 weeks: depth of notch gives information on probability of adverse pregnancy outcome and degree of fetal growth restriction in a low-risk population.
    Becker R; Vonk R
    Fetal Diagn Ther; 2010; 27(2):78-86. PubMed ID: 20093804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance and Outcomes of Fetal Growth Restriction Below the 5th Percentile Compared to the 5th to 10th Percentiles on Midgestation Growth Ultrasonography.
    Zhang-Rutledge K; Mack LM; Mastrobattista JM; Gandhi M
    J Ultrasound Med; 2018 Sep; 37(9):2243-2249. PubMed ID: 29476559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Perinatal variables and neonatal outcomes in severely growth restricted preterm fetuses.
    Engineer N; Kumar S
    Acta Obstet Gynecol Scand; 2010 Sep; 89(9):1174-81. PubMed ID: 20804344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adverse maternal and neonatal outcomes among women with preeclampsia with severe features <34 weeks gestation with versus without comorbidity.
    Venkatesh KK; Strauss RA; Westreich DJ; Thorp JM; Stamilio DM; Grantz KL
    Pregnancy Hypertens; 2020 Apr; 20():75-82. PubMed ID: 32193149
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The growth-restricted fetus: risk of mortality by each additional week of expectant management.
    Pilliod RA; Page JM; Sparks TN; Caughey AB
    J Matern Fetal Neonatal Med; 2019 Feb; 32(3):442-447. PubMed ID: 28974133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expectant management of severe preterm preeclampsia: a comparison of maternal and fetal indications for delivery.
    Mooney SS; Lee RM; Tong S; Brownfoot FC
    J Matern Fetal Neonatal Med; 2016 Dec; 29(23):3821-6. PubMed ID: 26940295
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pregnancies complicated by both preeclampsia and growth restriction between 34 and 37 weeks' gestation are associated with adverse perinatal outcomes.
    Sharma KJ; Esakoff TF; Guillet A; Burwick RM; Caughey AB
    J Matern Fetal Neonatal Med; 2017 Oct; 30(19):2342-2345. PubMed ID: 27756175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Management of preeclampsia.
    Dekker GA
    Pregnancy Hypertens; 2014 Jul; 4(3):246-7. PubMed ID: 26104648
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expectant management of severe preeclampsia at less than 27 weeks' gestation: maternal and perinatal outcomes according to gestational age by weeks at onset of expectant management.
    Bombrys AE; Barton JR; Nowacki EA; Habli M; Pinder L; How H; Sibai BM
    Am J Obstet Gynecol; 2008 Sep; 199(3):247.e1-6. PubMed ID: 18771971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Maternal and neonatal outcome of twin pregnancies complicated by single fetal death.
    Axt R; Mink D; Hendrik J; Ertan K; von Blohn M; Schmidt W
    J Perinat Med; 1999; 27(3):221-7. PubMed ID: 10503185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between arterial and venous Doppler and perinatal outcome in fetal growth restriction.
    Baschat AA; Gembruch U; Reiss I; Gortner L; Weiner CP; Harman CR
    Ultrasound Obstet Gynecol; 2000 Oct; 16(5):407-13. PubMed ID: 11169323
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Maternal and perinatal outcome in pregnancies complicated with hypertensive disorder of pregnancy: a seven year experience of a tertiary care center.
    Yücesoy G; Ozkan S; Bodur H; Tan T; Calişkan E; Vural B; Corakçi A
    Arch Gynecol Obstet; 2005 Nov; 273(1):43-9. PubMed ID: 15834580
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.